Clinical Trials in France / NCT05051046
Recruiting
Not applicable
Colorectal Cancer Screnning Colonoscopy Under Hypnosis
NCT05051046 · tracked via the Priya Life Science France tracker
Condition(s) studied
Colorectal (Colon or Rectal) Cancer
Investigational drug(s) / intervention(s)
Colonoscopy under hypnosis
Colonoscopy under hypnosis: The hypnosis used will be of the Ericksonian type. Before the colonoscopy begins, the IDE puts the patient in a hypnotic situation.
Study summary
Through this study, the effectiveness of hypnosis in the realization of a colonoscopy for the detection of colorectal cancer will be evaluated
Eligibility
Inclusion Criteria:
* Patients 18 years of age or older
* Undergoing a screening colonoscopy (mass screening Fecal Immunochemical Test positive or as an individual (family history of colon cancer or adenoma, personal history of adenoma, cancer, chronic inflammatory bowel disease) or in the context of a transit disorder, hemorrhage or anemia
* Affiliated with a French social security system
* Having signed a written consent
Exclusion Criteria:
* Patient requiring emergency colonoscopy
* History of colonic resection
* Carriers of behavioral disorders and/or psychiatric illness
* Limited cognitive abilities making it impossible to read or fill out a discrete choice questionnaire (language problems, comprehension problems)
* Contraindication to hypnosis, preventing quality interaction (comprehension and/or language problems, hearing impairment)
* Contraindication to general anesthesia
* Under a legal protection regime
* Pregnant or breastfeeding woman
Primary outcome measure(s)
- Rate of complete colonoscopies — The day of the colonoscopy, from the start to the end of the colonoscopy
Rate of complete colonoscopies: a colonoscopy is said to be complete when the endoscopist visualizes the caecal fundus.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Chu Angers | Angers | France | Recruiting |
More University Hospital, Tours trials in France
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05051046 on ClinicalTrials.gov ↗ ← All trials in France